Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
Grifols SA (GRF SM)
Watchlist
83
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
MSCI World Index
•
12 Aug 2019 09:31
Global Equity Strategy: Another Test of Support
Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...
Vermilion Research
Follow
479 Views
Share
bullish
•
China Biologic Products
•
19 Mar 2019 03:30
China Blood Products: Deals Highlight Values
Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...
Kemp Dolliver, CFA
720 Views
Share
bullish
•
CSL Ltd
•
10 Oct 2017 09:55
Not All Players Are Equal in the Plasma Industry
According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...
JCP Investment Partners
427 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 13:50
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
Dion Stéfan Büchner M.D., FCAP
595 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Dec 2016 11:44
American Society of Hematology- (ASH) Annual Conference (2016) Review
We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...
Dion Stéfan Büchner M.D., FCAP
461 Views
Share
First
Previous
13
14
15
16
17
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.60.0
x